# Arexis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arexis

- Industry: Pharmaceuticals
- Headquarters: Gothenburg, Sweden
- Total disclosed funding: $7.9M
- Latest round: Series B (Jul 9, 2003)
- Investors on record: 4

## About

Founded in 1999, Arexis AB operates as an integrated pharmaceutical company in Sweden. The company focuses on aspects of inflammation. They were acquired by Biovitrum AB in 2005.

## Funding rounds

- Series B, Jul 9, 2003, $7.9M — 3i, InnovationsKapital, Industrifonden, SEB

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series B
- InnovationsKapital (https://capitalatlas.ai/funds/innovationskapital) — Series B
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series B
- SEB — Series B